Monogram Orthopaedics Inc. Common Stock (MGRM) - Total Liabilities
Based on the latest financial reports, Monogram Orthopaedics Inc. Common Stock (MGRM) has total liabilities worth $6.38 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MGRM financial resilience to evaluate the company's liquid asset resilience ratio.
Monogram Orthopaedics Inc. Common Stock - Total Liabilities Trend (2017–2024)
This chart illustrates how Monogram Orthopaedics Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see MGRM asset base.
Monogram Orthopaedics Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Monogram Orthopaedics Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Global Water Resources Inc
NASDAQ:GWRS
|
USA | $391.03 Million |
|
Aviat Networks Inc
NASDAQ:AVNW
|
USA | $331.57 Million |
|
Newron Pharmaceuticals SpA
SW:NWRN
|
Switzerland | CHF51.15 Million |
|
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA
|
USA | $25.49 Million |
|
Panora Gayrimenkul Yatirim Ortakligi AS
IS:PAGYO
|
Turkey | TL1.46 Billion |
|
Poya International Co Ltd
TWO:5904
|
Taiwan | NT$23.55 Billion |
|
Santhera Pharmaceuticals Holding AG
SW:SANN
|
Switzerland | CHF159.90 Million |
|
Bioteque
TWO:4107
|
Taiwan | NT$1.43 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down Monogram Orthopaedics Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MGRM equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Monogram Orthopaedics Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Monogram Orthopaedics Inc. Common Stock (2017–2024)
The table below shows the annual total liabilities of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $3.27 Million | +2.67% |
| 2023-12-31 | $3.18 Million | -66.65% |
| 2022-12-31 | $9.54 Million | +83.05% |
| 2021-12-31 | $5.21 Million | +66.71% |
| 2020-12-31 | $3.13 Million | +8.00% |
| 2019-12-31 | $2.89 Million | +12.41% |
| 2018-12-31 | $2.58 Million | +144.83% |
| 2017-12-31 | $1.05 Million | -- |
About Monogram Orthopaedics Inc. Common Stock
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and ot… Read more